Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Denali Therapeutics (DNLI) Debt to Equity (2022)

Denali Therapeutics (DNLI) has disclosed Debt to Equity for 1 consecutive years, with $0.0 as the latest value for Q4 2022.

  • Quarterly Debt to Equity changed N/A to $0.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $0.0 through Dec 2022, changed N/A year-over-year, with the annual reading at $0.0 for FY2022, N/A changed from the prior year.
  • Debt to Equity for Q4 2022 was $0.0 at Denali Therapeutics, up from $0.0 in the prior quarter.
  • The five-year high for Debt to Equity was $0.0 in Q4 2022, with the low at $0.0 in Q3 2022.